Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 566

1.

Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.

Takeuchi K, Smale S, Premchand P, Maiden L, Sherwood R, Thjodleifsson B, Bjornsson E, Bjarnason I.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):196-202.

PMID:
16469680
[PubMed - indexed for MEDLINE]
2.

Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

Kefalakes H, Stylianides TJ, Amanakis G, Kolios G.

Eur J Clin Pharmacol. 2009 Oct;65(10):963-70. doi: 10.1007/s00228-009-0719-3. Epub 2009 Aug 27. Review.

PMID:
19711064
[PubMed - indexed for MEDLINE]
4.
5.

Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.

Asero R.

Ann Allergy Asthma Immunol. 1999 Jun;82(6):554-8.

PMID:
10400483
[PubMed - indexed for MEDLINE]
6.

Safe full-dose one-step nabumetone challenge in patients with nonsteroidal anti-inflammatory drug hypersensitivity.

Confino-Cohen R, Goldberg A.

Allergy Asthma Proc. 2003 Jul-Aug;24(4):281-4.

PMID:
12974196
[PubMed - indexed for MEDLINE]
7.

Selective COX-2 inhibitors and human inflammatory bowel disease.

McCartney SA, Mitchell JA, Fairclough PD, Farthing MJ, Warner TD.

Aliment Pharmacol Ther. 1999 Aug;13(8):1115-7.

PMID:
10468690
[PubMed - indexed for MEDLINE]
Free Article
8.

Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.

Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Køber L, Madsen M, Torp-Pedersen C.

Circulation. 2006 Jun 27;113(25):2906-13. Epub 2006 Jun 19.

PMID:
16785336
[PubMed - indexed for MEDLINE]
Free Article
9.

Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen.

Shah AA, Thjodleifsson B, Murray FE, Kay E, Barry M, Sigthorsson G, Gudjonsson H, Oddsson E, Price AB, Fitzgerald DJ, Bjarnason I.

Gut. 2001 Mar;48(3):339-46.

PMID:
11171823
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.

Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, Nizankowska E, Isakson PC, Mejza F, Lefkowith JB, Dahlén SE, Szczeklik A, Murray JJ, Dahlén B.

J Allergy Clin Immunol. 2003 May;111(5):1116-21.

PMID:
12743579
[PubMed - indexed for MEDLINE]
11.

Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.

Bavbek S, Celik G, Ozer F, Mungan D, Misirligil Z.

J Asthma. 2004 Feb;41(1):67-75.

PMID:
15046380
[PubMed - indexed for MEDLINE]
12.

Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract.

Bjarnason I, Thjodleifsson B.

Rheumatology (Oxford). 1999 May;38 Suppl 1:24-32. Review.

PMID:
10369403
[PubMed - indexed for MEDLINE]
Free Article
13.

Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.

[No authors listed]

Prescrire Int. 2007 Dec;16(92):223-7.

PMID:
18084859
[PubMed - indexed for MEDLINE]
14.

Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria.

Asero R.

Ann Allergy Asthma Immunol. 2006 Aug;97(2):187-9.

PMID:
16937749
[PubMed - indexed for MEDLINE]
15.

Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.

Senna G, Bilò MB, Antonicelli L, Schiappoli M, Crivellaro MA, Bonadonna P, Dama AR.

Eur Ann Allergy Clin Immunol. 2004 Jun;36(6):215-8.

PMID:
15329003
[PubMed - indexed for MEDLINE]
16.

Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives.

Cipolla G, Crema F, Sacco S, Moro E, de Ponti F, Frigo G.

Pharmacol Res. 2002 Jul;46(1):1-6. Review.

PMID:
12208114
[PubMed - indexed for MEDLINE]
17.

Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.

Hedner T, Samulesson O, Währborg P, Wadenvik H, Ung KA, Ekbom A.

Drugs. 2004;64(20):2315-43; discussion 2344-5. Review.

PMID:
15456329
[PubMed - indexed for MEDLINE]
18.

A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease.

Bonner GF, Fakhri A, Vennamaneni SR.

Inflamm Bowel Dis. 2004 Nov;10(6):751-7.

PMID:
15626893
[PubMed - indexed for MEDLINE]
19.

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.

Mahadevan U, Loftus EV Jr, Tremaine WJ, Sandborn WJ.

Am J Gastroenterol. 2002 Apr;97(4):910-4.

PMID:
12008668
[PubMed - indexed for MEDLINE]
20.

Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.

Goldstein JL, Cryer B, Amer F, Hunt B.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1167-74.

PMID:
17916545
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk